Eastwood Bio-Medical Canada Inc (EBM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eastwood Bio-Medical Canada Inc (EBM) has a cash flow conversion efficiency ratio of 0.001x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-900.00 ≈ $-651.05 USD) by net assets (CA$-1.65 Million ≈ $-1.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Eastwood Bio-Medical Canada Inc fund operations to measure how many days the company can operate on defensive assets alone.
Eastwood Bio-Medical Canada Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Eastwood Bio-Medical Canada Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Eastwood Bio-Medical Canada Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eastwood Bio-Medical Canada Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
WooGene B&G Co. Ltd
KQ:018620
|
0.015x |
|
InfoBeans Technologies Limited
NSE:INFOBEAN
|
0.143x |
|
HCL Infosystems Limited
NSE:HCL-INSYS
|
-0.001x |
|
Korea Computer Inc
KQ:054040
|
0.041x |
|
Mccoy Global Inc
TO:MCB
|
0.017x |
|
Singular Health Group Ltd
AU:SHG
|
-0.266x |
|
Claranova SE
PA:CLA
|
-1.143x |
|
SOLUCIONES CUATROO.EO-04
F:5XW
|
N/A |
Annual Cash Flow Conversion Efficiency for Eastwood Bio-Medical Canada Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Eastwood Bio-Medical Canada Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see EBM company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-10-31 | CA$-1.63 Million ≈ $-1.18 Million |
CA$19.30K ≈ $13.96K |
-0.012x | -200.95% |
| 2024-10-31 | CA$-1.30 Million ≈ $-937.99K |
CA$-15.22K ≈ $-11.01K |
0.012x | -41.57% |
| 2023-10-31 | CA$-840.80K ≈ $-608.22K |
CA$-16.89K ≈ $-12.22K |
0.020x | +37.61% |
| 2022-10-31 | CA$-294.20K ≈ $-212.82K |
CA$-4.29K ≈ $-3.11K |
0.015x | -98.19% |
| 2021-10-31 | CA$-144.32K ≈ $-104.40K |
CA$-116.21K ≈ $-84.07K |
0.805x | +168.15% |
| 2020-10-31 | CA$459.27K ≈ $332.23K |
CA$-542.69K ≈ $-392.58K |
-1.182x | -770.13% |
| 2019-10-31 | CA$1.31 Million ≈ $948.87K |
CA$-178.13K ≈ $-128.86K |
-0.136x | +43.59% |
| 2018-10-31 | CA$1.89 Million ≈ $1.37 Million |
CA$-454.79K ≈ $-328.99K |
-0.241x | -87.18% |
| 2017-10-31 | CA$2.76 Million ≈ $2.00 Million |
CA$-355.28K ≈ $-257.00K |
-0.129x | -34.57% |
| 2016-10-31 | CA$3.21 Million ≈ $2.32 Million |
CA$-306.58K ≈ $-221.77K |
-0.096x | -31.67% |
| 2015-10-31 | CA$3.73 Million ≈ $2.70 Million |
CA$-270.51K ≈ $-195.68K |
-0.073x | -118.34% |
| 2014-10-31 | CA$3.99 Million ≈ $2.88 Million |
CA$1.58 Million ≈ $1.14 Million |
0.396x | -67.40% |
| 2013-10-31 | CA$-208.29K ≈ $-150.68K |
CA$-252.88K ≈ $-182.93K |
1.214x | -- |
About Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appeti… Read more